INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 05, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $7.44 | 32,530 |
| May 05, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Open market or private sale of non-derivative or derivative security | 20,000 | $13.50 | 12,530 |
| May 05, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Open market or private sale of non-derivative or derivative security | 2,000 | $13.50 | 10,530 |
| May 05, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 15,000 |
| May 03, 2004 |
Director
Trans History: 476
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 100 | $6.00 | 5,358 |
| May 03, 2004 |
Director
Trans History: 476
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 100 | $12.59 | 5,258 |
| May 03, 2004 |
Director
Trans History: 476
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 200 | $6.00 | 5,458 |
| May 03, 2004 |
Director
Trans History: 476
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $12.54 | 5,258 |
| May 03, 2004 |
Director
Trans History: 476
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 500 | $6.00 | 5,758 |
| May 03, 2004 |
Director
Trans History: 476
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 500 | $12.64 | 5,258 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.